Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

not likely. I always check the literature. for example:

Given these observations, naltrexone was seen as a potential obesity treatment and several studies have been performed and published since the early 1980s. However, the results of these studies59–64 were disappointing, because naltrexone monotherapy was associated with minimal or no weight loss.29 The limited efficacy of a single obesity agent such as naltrexone might be explained because of the various different mechanisms regulating caloric intake and body weight.65 Therefore, a combination of drugs would be a better option.

Like that?? Minimal or no weight loss. hmmmmmmmmmmmmmmmm